Company Filing History:
2 out of 64 
2 out of 6 
2 out of 81 
Years Active: 2015-2019
Title: Igor Astsaturov: Innovator in Cancer Research
Introduction
Igor Astsaturov is a prominent inventor based in Philadelphia, PA, known for his significant contributions to cancer research. With a total of 4 patents, he has focused on developing innovative methods for the treatment and diagnosis of various cancers. His work has the potential to impact the lives of many patients suffering from hyperproliferative disorders.
Latest Patents
A few of Igor's latest patents include groundbreaking research on the EGFR/NEDD9/TGF-β interactome. This patent outlines methods for identifying agents that may be effective in treating hyperproliferative disorders. Another notable patent discusses the use of C-Myc as a biomarker for determining tumor sensitivity to RNA polymerase II inhibition. This research provides systems and methods for assessing whether cancer patients may respond to treatments involving RNA polymerase II inhibition, particularly in cases of pancreatic, ovarian, gastric, or esophageal cancers.
Career Highlights
Throughout his career, Igor has worked with esteemed organizations such as the Institute for Cancer Research and Nexuspharma, Inc. His dedication to advancing cancer treatment has established him as a key figure in the field of oncology research. His innovative approaches have garnered attention and respect from peers and industry professionals alike.
Collaborations
Igor has collaborated with notable colleagues, including Ilya G Serebriiskii and Vladimir Khazak. These partnerships have further enriched his research and contributed to the development of effective cancer therapies.
Conclusion
Igor Astsaturov's work exemplifies the spirit of innovation in cancer research. His patents and collaborations highlight his commitment to improving treatment options for patients facing challenging diagnoses. Through his efforts, he continues to pave the way for advancements in the field of oncology.